366 related articles for article (PubMed ID: 31046504)
1. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
[TBL] [Abstract][Full Text] [Related]
2. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
4. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents.
Alcusky M; Tjia J; McManus DD; Hume AL; Fisher M; Lapane KL
J Gen Intern Med; 2020 Aug; 35(8):2329-2337. PubMed ID: 32291717
[TBL] [Abstract][Full Text] [Related]
5. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
6. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
[TBL] [Abstract][Full Text] [Related]
8. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
[TBL] [Abstract][Full Text] [Related]
9. Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region - Analysis Using the National Health Insurance Database.
Narita N; Okumura K; Kinjo T; Mikami J; Tsushima K; Takahashi R; Noro M; Hashimoto A; Sasaki T; Takaki M; Ishidoya E; Narita Y; Imai H; Ono E; Tomita H
Circ J; 2020 Apr; 84(5):706-713. PubMed ID: 32213724
[TBL] [Abstract][Full Text] [Related]
10. Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation.
Park S; Je NK
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):57-64. PubMed ID: 31405298
[TBL] [Abstract][Full Text] [Related]
11. Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey.
Salehi Omran S; Parikh NS; Zambrano Espinoza M; Lerario MP; Levine SR; Kamel H; Marshall R; Willey J
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105291. PubMed ID: 32992194
[TBL] [Abstract][Full Text] [Related]
12. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and the factors associated with oral anticoagulant use among nursing home residents.
Chen Q; Lapane K; Nunes AP; Tjia J; Hugunin J; Alcusky M
J Clin Pharm Ther; 2021 Dec; 46(6):1714-1728. PubMed ID: 34463969
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
Amin A; Keshishian A; Dina O; Dhamane A; Nadkarni A; Carda E; Russ C; Rosenblatt L; Mardekian J; Yuce H; Baker CL
J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
[TBL] [Abstract][Full Text] [Related]
16. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
Martinez BK; Sood NA; Bunz TJ; Coleman CI
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
[TBL] [Abstract][Full Text] [Related]
18. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
[TBL] [Abstract][Full Text] [Related]
19. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
